Stereotaxis expects recurring revenue to reach $8M in Q4 2026 as MAGiC adoption remains supply constrained

EarningsMAGiCPositive

AI Analysis

Summary

Stereotaxis expects recurring revenue to reach $8M in Q4 2026 as MAGiC adoption remains supply constrained. The company is forecasting revenue growth despite ongoing supply limitations impacting product adoption rates.

Financial Highlights

Revenue

$8M recurring revenue expected Q4 2026

Guidance

Recurring revenue to reach $8M in Q4 2026

Importance:4/10

Sentiment:

0.50

recurring revenueguidancesupply constraintproduct adoption

Related Companies

$STX

Read the original article

Published by Seeking Alpha Healthcare on August 12, 2026 3:28 AM

Read Original